307(c)(1)(A) (21 U.S.C. 827(C)(1)(A)) is amended to read as follows: To the prescribing of controlled substances in schedule II, III, IV, or V by practitioners acting in the lawful course of their professional practice unless such substance is prescribed in the course of maintenance or detoxification treatment of an individual. Section 307(c)(1)(B) (21 U.S.C. 827(c)(1)(B)) is amended to read as follows: To the administering of a controlled substance in schedule II, III, IV, or V unless the practitioner regularly engages in the dispensing or administering of controlled substances and charges his patients, either separately or together with charges for other professional services, for substances so dispensed or administered or unless such substance is administered in the course of maintenance treatment or detoxification treatment of an individual. Section 307 (21 U.S.C. 827) is further amended by adding at the end a new subsection (g) as follows: Every registrant under this title shall be required to report any change of professional or business address in such manner as the Attorney General shall by regulation require. Section 403(a)(2) (21 U.S.C. 843(a)(2)) is amended to read as follows: To use in the course of the manufacture, distribution, or dispensing of a controlled substance, or to use for the purpose of acquiring or obtaining a controlled substance, a registration number which is fictitious, revoked, suspended, expired, or issued to another person. Section 1002(b)(2) (21 U.S.C 952(b)(2)) is amended to read as follows: Is imported pursuant to such notification, or declaration, or in the case of any nonnarcotic controlled substance in schedule III, such import permit, notification, or declaration, as the Attorney General may by regulation prescribe, except that if a nonnarcotic controlled substance in schedule IV or V is also listed in schedule I or II of the Convention on Psychotropic Substances it shall be imported pursuant to such import permit requirements, prescribed by regulation of the Attorney General, as are required by the Convention. Section 1003(e) (21 U.S.C. 953(e)) is amended to read as follows: It shall be unlawful to export from the United States to any other country any nonnarcotic controlled substance in schedule III or IV or any controlled substances in schedule V unless — (1) there is furnished (before export) to the Attorney General documentary proof that importation is not contrary to the laws or regulations of the country of destination for consumption for medical, scientific, or other legitimate purposes. (2)